{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:39:56Z","timestamp":1778755196388,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001407","name":"DBT","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"DST","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FIST"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.virusres.2020.198169","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T08:25:07Z","timestamp":1600935907000},"page":"198169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"special_numbering":"C","title":["Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection"],"prefix":"10.1016","volume":"290","author":[{"given":"Prashant","family":"Khare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Utkarsha","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish Chandra","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0154-2421","authenticated-orcid":false,"given":"Mukesh","family":"Samant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.virusres.2020.198169_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036521","article-title":"Mechanism of nucleic acid unwinding by SARS-CoV helicase","volume":"7","author":"Adedeji","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.virusres.2020.198169_bib0010","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"issue":"25","key":"10.1016\/j.virusres.2020.198169_bib0015","doi-asserted-by":"crossref","first-page":"15189","DOI":"10.1128\/JVI.79.24.15189-15198.2005","article-title":"The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity","volume":"79","author":"Barretto","year":"2005","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virusres.2020.198169_bib0020","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3390\/v4061011","article-title":"Mechanisms of coronavirus cell entry mediated by the viral spike protein","volume":"4","author":"Belouzard","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2020.198169_bib0025","series-title":"Potential Natural Compounds for Preventing 2019-nCoV Infection Preprint","author":"Chen","year":"2020"},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcv.2004.03.003","article-title":"In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds","volume":"31","author":"Chen","year":"2004","journal-title":"J. Clin. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2020.198169_bib0035","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/ecam\/neh081","article-title":"Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3, 3\u2019-digallate (TF3)","volume":"2","author":"Chen","year":"2005","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0040","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jep.2008.07.048","article-title":"Toona sinensis Roem tender leaf extract inhibits SARS coronavirus replication","volume":"120","author":"Chen","year":"2008","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.virusres.2020.198169_bib0045","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1440-1681.2006.04415.x","article-title":"Antiviral effects of saikosaponins on human coronavirus 229E in vitro","volume":"33","author":"Cheng","year":"2006","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.virusres.2020.198169_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173372","article-title":"Advances in the possible treatment of COVID-19: a review","author":"Chibber","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"9374","key":"10.1016\/j.virusres.2020.198169_bib0055","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","article-title":"Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus","volume":"361","author":"Cinatl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.virusres.2020.198169_bib0060","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2174\/138161206776361147","article-title":"Understanding helicases as a means of virus control","volume":"12","author":"Frick","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.virusres.2020.198169_bib0065","first-page":"41","article-title":"Immunomodulatory activities of the herbal formula Kwan Du Bu Fei Dang in healthy subjects: a randomised, double-blind, placebo-controlled study","volume":"17","author":"Fung","year":"2011","journal-title":"Hong Kong Med. J."},{"issue":"4","key":"10.1016\/j.virusres.2020.198169_bib0070","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s13337-015-0276-6","article-title":"Herbal plants and plant preparations as remedial approach for viral diseases","volume":"26","author":"Ganjhu","year":"2015","journal-title":"Virusdisease"},{"key":"10.1016\/j.virusres.2020.198169_bib0075","doi-asserted-by":"crossref","DOI":"10.1002\/cpt.1856","article-title":"Optimizing hydroxychloroquine dosing for patients with COVID-19: an integrative modeling approach for effective drug repurposing","author":"Garcia-Cremades","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.virusres.2020.198169_bib0080","article-title":"Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency","author":"Gordon","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.1016\/j.virusres.2020.198169_bib0085","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1111\/febs.12936","article-title":"From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design","volume":"281","author":"Hilgenfeld","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.virusres.2020.198169_bib0090","doi-asserted-by":"crossref","DOI":"10.1002\/phar.2403","article-title":"Delayed initiation of remdesivir in a COVID-19 positive patient","author":"Hillaker","year":"2020","journal-title":"Pharmacotherapy."},{"issue":"2","key":"10.1016\/j.virusres.2020.198169_bib0095","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.antiviral.2006.04.014","article-title":"Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction","volume":"72","author":"Ho","year":"2007","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2020.198169_bib0100","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","article-title":"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health-The latest 2019 novel coronavirus outbreak in Wuhan, China","volume":"91","author":"Hui","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.virusres.2020.198169_bib0105","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.6700","article-title":"Natural products and their derivatives against coronavirus: a review of the nonclinical and preclinical data","author":"Islam","year":"2020","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.virusres.2020.198169_bib0110","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2217\/fvl-2018-0144","article-title":"Membrane binding proteins of coronaviruses","volume":"14","author":"J Alsaadi","year":"2019","journal-title":"Future Virol."},{"issue":"2\u20133","key":"10.1016\/j.virusres.2020.198169_bib0115","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0014-5793(02)02311-6","article-title":"Induction of inducible nitric oxide synthase expression by 18\u03b2-glycyrrhetinic acid in macrophages","volume":"513","author":"Jeong","year":"2002","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14756366.2019.1690480","article-title":"Inhibition of SARS-CoV 3CL protease by flavonoids","volume":"35","author":"Jo","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.virusres.2020.198169_bib0125","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1128\/JVI.02130-09","article-title":"NTPase and 5\u2019 to 3\u2019 RNA duplex-unwinding activities of the hepatitis E virus helicase domain","volume":"84","author":"Karpe","year":"2010","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0130","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/14756366.2012.753591","article-title":"Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia","volume":"29","author":"Kim","year":"2014","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"11","key":"10.1016\/j.virusres.2020.198169_bib0135","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/biom9110696","article-title":"Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, inhibit human coronavirus OC43 infection of MRC-5 human lung cells","volume":"9","author":"Kim","year":"2019","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.virusres.2020.198169_bib0140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0040-4039(91)80845-W","article-title":"Halitunal, an unusual diterpene aldehyde from the marine alga Halimeda tuna","volume":"32","author":"Koehn","year":"1991","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.virusres.2020.198169_bib0145","first-page":"1","article-title":"Drug repurposing studies targeting SARS-CoV-2: an ensemble docking approach on drug target 3C-like protease (3CLpro)","author":"Koulgi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0150","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jep.2008.03.018","article-title":"Immunomodulatory and anti-SARS activities of Houttuynia cordata","volume":"118","author":"Lau","year":"2008","journal-title":"J. Ethnopharmacol."},{"issue":"6965","key":"10.1016\/j.virusres.2020.198169_bib0155","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0160","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.antiviral.2005.02.007","article-title":"Identification of natural compounds with antiviral activities against SARS-associated coronavirus","volume":"67","author":"Li","year":"2005","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0165","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.antiviral.2005.07.002","article-title":"Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds","volume":"68","author":"Lin","year":"2005","journal-title":"Antiviral Res."},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0170","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/2225-4110.124335","article-title":"Antiviral natural products and herbal medicines","volume":"4","author":"Lin","year":"2014","journal-title":"J. Tradit. Complement. Med."},{"issue":"24","key":"10.1016\/j.virusres.2020.198169_bib0175","doi-asserted-by":"crossref","first-page":"15199","DOI":"10.1128\/JVI.79.24.15199-15208.2005","article-title":"The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme","volume":"79","author":"Lindner","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2020.198169_bib0180","first-page":"2991","article-title":"The coronavirus nucleocapsid is a multifunctional protein","volume":"6","author":"McBride","year":"2014","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.virusres.2020.198169_bib0185","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.3390\/md13074520","article-title":"Potential antiviral agents from marine fungi: an overview","volume":"13","author":"Moghadamtousi","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.virusres.2020.198169_bib0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/6491738","article-title":"Middle east respiratory syndrome coronavirus (MERS-CoV): infection, immunological response, and vaccine development","volume":"2019","author":"Mubarak","year":"2019","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00253-010-2578-3","article-title":"Synthetic biology approaches in drug discovery and pharmaceutical biotechnology","volume":"87","author":"Neumann","year":"2010","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.virusres.2020.198169_bib0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41422-020-0290-0","article-title":"Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses","author":"Nguyen","year":"2020","journal-title":"Cell Res."},{"issue":"3","key":"10.1016\/j.virusres.2020.198169_bib0205","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/molecules22030505","article-title":"Potential antivirals: natural products targeting replication enzymes of dengue and chikungunya viruses","volume":"22","author":"Oliveira","year":"2017","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.virusres.2020.198169_bib0210","doi-asserted-by":"crossref","first-page":"144","DOI":"10.21010\/ajtcam.v13i6.20","article-title":"Selective inhibition of hepatitis c virus replication by Alpha-zam, a Nigella sativa seed formulation","volume":"13","author":"Oyero","year":"2016","journal-title":"Afr. J. Tradit. Complement. Altern. Med."},{"key":"10.1016\/j.virusres.2020.198169_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117956","article-title":"Vaccination strategies to combat novel corona virus SARS-CoV-2","author":"Pandey","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.virusres.2020.198169_bib0220","first-page":"b12","article-title":"Diarylheptanoids from Alnus japonica inhibit papain-like protease of severe acute respiratory syndrome coronavirus","author":"Park","year":"2012","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0225","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/14756366.2014.1003215","article-title":"Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV","volume":"31","author":"Park","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0230","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/14756366.2016.1265519","article-title":"Evaluation of polyphenols from Broussonetia papyrifera as coronavirus protease inhibitors","volume":"32","author":"Park","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.virusres.2020.198169_bib0235","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMe2001126","article-title":"Another decade, another coronavirus","author":"Perlman","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2020.198169_bib0240","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.26633\/RPSP.2020.40","article-title":"Clinical trials on drug repositioning for COVID-19 treatment","volume":"44","author":"Rosa","year":"2020","journal-title":"Rev. Panam. Salud Publica"},{"issue":"22","key":"10.1016\/j.virusres.2020.198169_bib0245","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1016\/j.bmc.2010.09.035","article-title":"Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition","volume":"18","author":"Ryu","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.virusres.2020.198169_bib0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104793","article-title":"Remdesivir and SARS-CoV-2: structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites","author":"Shannon","year":"2020","journal-title":"Antiviral Res."},{"issue":"SI-1","key":"10.1016\/j.virusres.2020.198169_bib0255","doi-asserted-by":"crossref","first-page":"611","DOI":"10.3906\/sag-2004-145","article-title":"Antiviral treatment of COVID-19","volume":"50","author":"Simsek Yavuz","year":"2020","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.virusres.2020.198169_bib0260","doi-asserted-by":"crossref","DOI":"10.1038\/s41401-020-0483-6","article-title":"Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients","author":"Su","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.virusres.2020.198169_bib0265","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1099\/vir.0.19424-0","article-title":"Mechanisms andenzymes involved in SARS coronavirus genome expression","volume":"84","author":"Thiel","year":"2003","journal-title":"J. Gen. Virol."},{"issue":"14","key":"10.1016\/j.virusres.2020.198169_bib0270","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1021\/acsomega.0c00772","article-title":"Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil","volume":"5","author":"Thuy","year":"2020","journal-title":"ACS Omega"},{"issue":"7","key":"10.1016\/j.virusres.2020.198169_bib0275","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072657","article-title":"A review of SARS-CoV-2 and the ongoing clinical trials","volume":"21","author":"Tu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.virusres.2020.198169_bib0280","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s11033-014-3019-7","article-title":"The effects of Nigella sativa (Ns), Anthemis hyalina (Ah) and Citrus sinensis (Cs) extracts on the replication of coronavirus and the expression of TRP genes family","volume":"41","author":"Ulasli","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.virusres.2020.198169_bib0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejim.2020.04.037","article-title":"The pivotal link between ACE2 deficiency and SARS-CoV-2 infection","author":"Verdecchia","year":"2020","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.virusres.2020.198169_bib0290","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07391102.2020.1762743","article-title":"Stilbene-based natural compounds as promising drug candidates against COVID-19","author":"Wahedi","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.virusres.2020.198169_bib0295","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3390\/md12042019","article-title":"Potential anti-HPV and related cancer agents from marine resources: an overview","volume":"12","author":"Wang","year":"2014","journal-title":"Mar. Drugs"},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0300","article-title":"Neuroprotective effect of Scutellarin on ischemic cerebral injury by down-regulating the expression of angiotensin-converting enzyme and AT1 receptor","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.virusres.2020.198169_bib0305","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res."},{"issue":"17","key":"10.1016\/j.virusres.2020.198169_bib0310","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/jm070295s","article-title":"Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus","volume":"50","author":"Wen","year":"2007","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.virusres.2020.198169_bib0315","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2225-4110(16)30055-4","article-title":"Traditional Chinese medicine herbal extracts of Cibotiumbarometz, Gentianascabra, Dioscoreabatatas, Cassia tora, and taxilluschinensis inhibit SARS-CoV replication","volume":"1","author":"Wen","year":"2011","journal-title":"J. Tradit. Complement. Med."},{"issue":"6","key":"10.1016\/j.virusres.2020.198169_bib0320","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/bph.14943","article-title":"Trends in use, pharmacology, and clinical applications of emerging herbal nutraceuticals","volume":"177","author":"Williamson","year":"2020","journal-title":"British J. Pharmacolog"},{"issue":"2","key":"10.1016\/j.virusres.2020.198169_bib0325","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.antiviral.2010.08.009","article-title":"Identification of phenanthroindolizines and phenanthroquinolizidines as novel potent anti-coronaviral agents for porcine enteropathogenic coronavirus transmissible gastroenteritis virus and human severe acute respiratory syndrome coronavirus","volume":"88","author":"Yang","year":"2010","journal-title":"Antiviral Res."},{"issue":"20","key":"10.1016\/j.virusres.2020.198169_bib0330","doi-asserted-by":"crossref","first-page":"11334","DOI":"10.1128\/JVI.78.20.11334-11339.2004","article-title":"Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells","volume":"78","author":"Yi","year":"2004","journal-title":"J. Virol."},{"issue":"12","key":"10.1016\/j.virusres.2020.198169_bib0335","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1016\/j.bmcl.2012.04.081","article-title":"Identification of myricetin and scutellarein as novel chemical inhibitors of the SARS coronavirus helicase, nsP13","volume":"22","author":"Yu","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.virusres.2020.198169_bib0340","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"issue":"7798","key":"10.1016\/j.virusres.2020.198169_bib0345","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2020.198169_bib0350","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170220310765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170220310765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T14:10:00Z","timestamp":1759155000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170220310765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":70,"alternative-id":["S0168170220310765"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2020.198169","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2020.198169","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"198169"}}